These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24260284)

  • 1. CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes.
    Bloom AJ; Martinez M; Chen LS; Bierut LJ; Murphy SE; Goate A
    PLoS One; 2013; 8(11):e79700. PubMed ID: 24260284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
    Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline.
    Tomaz PRX; Kajita MS; Santos JR; Scholz J; Abe TO; Gaya PV; Krieger JE; Pereira AC; Santos PCJL
    Eur J Clin Pharmacol; 2019 Nov; 75(11):1541-1545. PubMed ID: 31402421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
    Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
    Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.
    Lee AM; Jepson C; Hoffmann E; Epstein L; Hawk LW; Lerman C; Tyndale RF
    Biol Psychiatry; 2007 Sep; 62(6):635-41. PubMed ID: 17223085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people.
    Binnington MJ; Zhu AZ; Renner CC; Lanier AP; Hatsukami DK; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2012 Jun; 22(6):429-40. PubMed ID: 22569203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.
    Bloom J; Hinrichs AL; Wang JC; von Weymarn LB; Kharasch ED; Bierut LJ; Goate A; Murphy SE
    Pharmacogenet Genomics; 2011 Jul; 21(7):403-16. PubMed ID: 21597399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.
    Claw KG; Beans JA; Lee SB; Avey JP; Stapleton PA; Scherer SE; El-Boraie A; Tyndale RF; Nickerson DA; Dillard DA; Thummel KE; Robinson RF
    Nicotine Tob Res; 2020 May; 22(6):910-918. PubMed ID: 31241144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
    Tomaz PR; Santos JR; Issa JS; Abe TO; Gaya PV; Krieger JE; Pereira AC; Santos PC
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1067-73. PubMed ID: 26153084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys.
    Ferguson CS; Miksys S; Palmour RM; Tyndale RF
    J Pharmacol Exp Ther; 2012 Dec; 343(3):628-37. PubMed ID: 22935730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of alleles, genotypes and haplotypes of the CYP2B6 (rs3745274; rs2279343) and CYP3A4 (rs2740574) genes in the Malian population: Implication for pharmacogenetics.
    Kassogue Y; Diakite B; Kassogue O; Konate I; Tamboura K; Diarra Z; Maiga M; Dehbi H; Nadifi S; Traore CB; Kamate B; Dao S; Doumbia S; Dolo G
    Medicine (Baltimore); 2021 Jul; 100(29):e26614. PubMed ID: 34398016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.
    Piliguian M; Zhu AZ; Zhou Q; Benowitz NL; Ahluwalia JS; Sanderson Cox L; Tyndale RF
    Pharmacogenet Genomics; 2014 Feb; 24(2):118-28. PubMed ID: 24305170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.
    Ray R; Tyndale RF; Lerman C
    J Neurogenet; 2009; 23(3):252-61. PubMed ID: 19169923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: identification of novel variant CYP2B6 alleles.
    Restrepo JG; Martínez C; García-Agúndez A; Gaviria E; Laguna JJ; García-Martín E; Agúndez JA
    Pharmacogenet Genomics; 2011 Dec; 21(12):773-8. PubMed ID: 21886015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6.
    Satarug S; Tassaneeyakul W; Na-Bangchang K; Cashman JR; Moore MR
    Curr Clin Pharmacol; 2006 Sep; 1(3):291-309. PubMed ID: 18666753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C19 Plays a Major Role in the Hepatic
    Perez-Paramo YX; Watson CJW; Chen G; Lazarus P
    Drug Metab Dispos; 2023 Jan; 51(1):29-37. PubMed ID: 35197312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions.
    Yamanaka H; Nakajima M; Fukami T; Sakai H; Nakamura A; Katoh M; Takamiya M; Aoki Y; Yokoi T
    Drug Metab Dispos; 2005 Dec; 33(12):1811-8. PubMed ID: 16135656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour.
    Tricker AR
    Toxicology; 2003 Feb; 183(1-3):151-73. PubMed ID: 12504349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.